Skip to content

SORRENTO THERAPEUTICS, INC.

CIK 0000850261

← back to feed
Revenue (TTM)
$137.7M
+125.6% YoY Q2 Aug 2023
Net Income (TTM)
−$543.16M
−296.7% YoY Q2 Aug 2023
EPS Diluted (TTM)
−$1.17
−191.5% YoY Q2 Aug 2023
Gross Margin
93.5%
Q2 Aug 2023
Operating Margin
-298.8%
Q2 Aug 2023
Net Margin
-394.5%
Q2 Aug 2023
Free Cash Flow (TTM)
−$224.12M
Q2 Aug 2023
Cash
$69.75M
Q2 Aug 2023
Total Debt
$142.1M
Q2 Aug 2023
Shares Outstanding
551.28M sh
Q2 Aug 2023

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings